The Critical Role of the Clinical Research Coordinator for Clinical Trials: A Survey in Oncology

M. Cinefra, C. Cagnazzo, L. McMahon, F. Arizio, S. Campora, R. Camisa, G. Canzanella, M. Contu, P. Frati, R. Sottile, S. Gori, G. Procopio, O. Nanni
{"title":"The Critical Role of the Clinical Research Coordinator for Clinical Trials: A Survey in Oncology","authors":"M. Cinefra, C. Cagnazzo, L. McMahon, F. Arizio, S. Campora, R. Camisa, G. Canzanella, M. Contu, P. Frati, R. Sottile, S. Gori, G. Procopio, O. Nanni","doi":"10.5301/MAAPOC.0000015","DOIUrl":null,"url":null,"abstract":"Introduction Access to innovative medicine requires proper evidence from clinical trials with the growing demand of qualified and experienced personnel. The clinical research coordinator (CRC) plays an important role in the conduction of research activities and provides a strong support to the research team. In Italy, this role is not recognized at any institutional level and its professional outline is still indefinite. Several national associations (Associazione Italiana di Oncologia Medica, Collegio Italiano dei Primari Oncologi Medici Ospedalieri, Gruppo Italiano Data Manager) are committed to promoting the enhancement and recognition of the professional status of CRCs, underlining their role as fundamental. Methods A web survey, proposed by the AIOM CRC Working Group, was submitted to 319 Italian oncology sites with items focusing on the organization of sites, the research activities, the staff composition, and the presence of coordinators and the multidisciplinary team. Results A total of 115 sites (35.9%) responded to the web survey. Clinical studies were carried out at 88.7% of the investigated sites, and coordinators were on staff at 75.5% of the active investigational sites. Interestingly, there was a direct association between the number of clinical studies and the number of coordinators, whose contribution to the research activities is believed to be essential for trial conduct in 82.4% of cases. Most sites retain that the quality of clinical research has absolutely improved (83.3%) after the implementation of a coordinator as member of the team. Conclusions Given the constant growth of the number of clinical trials performed at Italian oncology sites, the CRC proves to be an essential component of the research team. However, there is an urgent need to institute the professional role alongside the need to standardize the training of coordinators to establish the minimum requirements enhanced by qualifying courses.","PeriodicalId":74158,"journal":{"name":"Medicine access @ point of care","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5301/MAAPOC.0000015","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine access @ point of care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5301/MAAPOC.0000015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Introduction Access to innovative medicine requires proper evidence from clinical trials with the growing demand of qualified and experienced personnel. The clinical research coordinator (CRC) plays an important role in the conduction of research activities and provides a strong support to the research team. In Italy, this role is not recognized at any institutional level and its professional outline is still indefinite. Several national associations (Associazione Italiana di Oncologia Medica, Collegio Italiano dei Primari Oncologi Medici Ospedalieri, Gruppo Italiano Data Manager) are committed to promoting the enhancement and recognition of the professional status of CRCs, underlining their role as fundamental. Methods A web survey, proposed by the AIOM CRC Working Group, was submitted to 319 Italian oncology sites with items focusing on the organization of sites, the research activities, the staff composition, and the presence of coordinators and the multidisciplinary team. Results A total of 115 sites (35.9%) responded to the web survey. Clinical studies were carried out at 88.7% of the investigated sites, and coordinators were on staff at 75.5% of the active investigational sites. Interestingly, there was a direct association between the number of clinical studies and the number of coordinators, whose contribution to the research activities is believed to be essential for trial conduct in 82.4% of cases. Most sites retain that the quality of clinical research has absolutely improved (83.3%) after the implementation of a coordinator as member of the team. Conclusions Given the constant growth of the number of clinical trials performed at Italian oncology sites, the CRC proves to be an essential component of the research team. However, there is an urgent need to institute the professional role alongside the need to standardize the training of coordinators to establish the minimum requirements enhanced by qualifying courses.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
临床试验临床研究协调员的关键作用:肿瘤学综述
获得创新药物需要来自临床试验的适当证据,对合格和有经验的人员的需求日益增长。临床研究协调员(CRC)在研究活动的开展中发挥着重要作用,为研究团队提供了强有力的支持。在意大利,这一作用没有得到任何机构级别的承认,其专业大纲仍然是不确定的。几个国家协会(Associazione Italiana di Oncologia Medica, Collegio Italiano dei Primari Oncologi Medici Ospedalieri, Gruppo Italiano Data Manager)致力于促进crc专业地位的提升和认可,强调其作为基础的作用。方法采用AIOM CRC工作组提出的网络调查方法,对意大利319家肿瘤中心进行调查,调查内容包括中心组织、研究活动、工作人员构成、协调员和多学科团队的存在情况。结果共有115家网站(35.9%)参与了网络调查。88.7%的调查地点开展了临床研究,75.5%的活跃研究地点有协调员。有趣的是,临床研究的数量与协调员的数量之间存在直接关联,在82.4%的病例中,协调员对研究活动的贡献被认为对试验进行至关重要。大多数网站认为,实施协调员作为团队成员后,临床研究质量绝对提高(83.3%)。鉴于在意大利肿瘤中心进行的临床试验数量不断增长,CRC被证明是研究团队的重要组成部分。但是,迫切需要确立专业人员的作用,同时也需要使协调员的培训标准化,以确定通过合格课程加强的最低要求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
15 weeks
期刊最新文献
A structural equation modeling of supply chain strategies for artemisinin-based combination therapies in Uganda. Antibiotic consumption at community pharmacies: A multicenter repeated prevalence surveillance using WHO methodology. Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria. Point-of-care high-sensitivity assay on PATHFAST as the backup in the emergency room. Medicine quality in high-income countries: The obstacles to comparative prevalence studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1